Paixão SVM, Silva CDCM. Lutetium-specific prostatic membrane antigen (luPSMA) treatment for metastatic castration- resistant prostate cancer. LEV [Internet]. 2024 Jul. 23 [cited 2025 Jan. 18];15(38):942-54. Available from: https://periodicos.newsciencepubl.com/LEV/article/view/65